The state of Washington currently has 15 active clinical trials seeking participants for Depression research studies. These trials are conducted in various cities, including Seattle, Spokane, Tacoma and Vancouver.
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
Recruiting
Efficacy, Safety, and Tolerability of two administrations of COMP360 in participants with treatment-resistant depression (TRD)
Gender:
All
Ages:
18 years and above
Trial Updated:
04/16/2024
Locations: Seattle Neuropsychiatric Treatment Center, Seattle, Washington
Conditions: Treatment Resistant Depression
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Recruiting
Objectives of this study are to determine whether active VNS Therapy treatment is superior to a no stimulation control in producing a reduction in baseline depressive symptom severity, based on multiple depression scale assessment tools at 12 months from randomization.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/11/2024
Locations: Center For Anxiety and Depression, Mercer Island, Washington +1 locations
Conditions: Treatment Resistant Depression
Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE
Recruiting
This study compares the effectiveness of technology-enhanced collaborative care management (t-CoCM) to usual collaborative care management (u-CoCM) in achieving fidelity to processes of care and reducing depression symptoms in patients currently receiving cancer treatment. CoCM is a population-based, integrated care approach, where care managers, who are clinicians (typically clinical social workers), deliver behavioral treatments, coordinate psychosocial care, monitor outcomes, and adjust treat... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
02/26/2024
Locations: MultiCare Regional Cancer Center - Gig Harbor, Gig Harbor, Washington +2 locations
Conditions: Depression, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD
Recruiting
A Phase 3, randomized, double-blind, placebo-controlled, multicenter trial of REL-1017 in patients with major depressive disorder (MDD).
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
02/15/2024
Locations: Relmada Site, Seattle, Washington
Conditions: Major Depressive Disorder, Depression
A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)
Recruiting
This is an outpatient, 2-arm, Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of REL-1017 once daily (QD) as an adjunctive treatment of Major Depressive Disorder. Study participants will continue to take their current antidepressant therapy in addition to the study drug or placebo for the duration of the treatment period.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
02/15/2024
Locations: Relmada Site, Bellevue, Washington +1 locations
Conditions: Major Depressive Disorder, Depression
Viome Precision Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions
Recruiting
US residents who have obesity and sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of two arms. This study is direct to participant and will not utilize clinical sites.
Gender:
All
Ages:
25 years and above
Trial Updated:
01/03/2024
Locations: Viome Life Sciences, Bothell, Washington
Conditions: Mental Health Issue, Mental Health Disorder, Mental Health, Depression, Depression, Anxiety, Anxiety, Anxiety Disorders, Anxiety Depression, Anxiety State
A Dyadic Approach to Perinatal Depression in Primary Care: Maternal Infant and Dyadic Care
Recruiting
The purpose of this study is to assess the effectiveness of a parenting intervention+usual care compared to usual care on postpartum depression and other mental health and parenting outcomes, as well as the feasibility and acceptability of the parenting intervention.
Gender:
Female
Ages:
18 years and above
Trial Updated:
12/18/2023
Locations: Amritha Bhat, Seattle, Washington
Conditions: Depression, Postpartum, Efficacy, Self, Anxiety
InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
Recruiting
The purpose of this randomized controlled trial is to evaluate whether the InMotion intervention, delivered via telehealth (using a HIPAA-compliant video platform or phone), which uses evidence-based behavioral and motivational counseling to increase daily physical activity, is an effective treatment for Major Depressive Disorder (MDD) for people who are at least one year out from sustaining a traumatic brain injury (TBI). The first aim is to compare the efficacy of the InMotion intervention to... Read More
Gender:
All
Ages:
Between 18 years and 64 years
Trial Updated:
11/27/2023
Locations: University of Washington Medical Center, Seattle, Washington
Conditions: TBI (Traumatic Brain Injury), Depressive Disorder, Major, Clinical Depression, Mood Depressed, Physical Inactivity
Poststroke Depression in Hemorrhagic Stroke
Recruiting
A double-blinded placebo-controlled randomized trial to evaluate the effect of preventative treatment of depression in survivors of aneurysmal subarachnoid hemorrhage (aSAH), a type of stroke.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
11/27/2023
Locations: Harborview Medical Center, Seattle, Washington
Conditions: Stroke Hemorrhagic, Depression
Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression
Recruiting
This study will evaluate the efficacy and safety of NV-5138 in adults with TRD
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
11/08/2023
Locations: Northwest Clinical Research Center, Inc., Bellevue, Washington
Conditions: Treatment Resistant Depression
MBCT Intervention: Healthy Mind, Healthy Living
Recruiting
Depression among older Korean Americans are rising. Mindfulness-based cognitive therapy (MBCT) is an evidence-based intervention (EBI), effective for preventing depression relapse and reducing depressive symptoms. To enhance feasibility, acceptability, and reach, a brief version of MBCT has been developed and delivered by telephone (brief MBCT-T), but has only been tested in primarily White samples. This study will test test the effect of brief MBCT-T among older Korean Americans.
Gender:
All
Ages:
Between 50 years and 89 years
Trial Updated:
11/01/2023
Locations: University of Washington, Seattle, Washington
Conditions: Mindfulness Based Cognitive Therapy, Depression, Sleep, Anxiety Depression
Yoga in the NICU for Parents Study
Recruiting
The purpose of this proposal is to test the efficacy of yoga as a mind and body intervention to decrease stress, anxiety, and depression in parents of critically ill neonates hospitalized in the Seattle Children's and University of Washington neonatal intensive care units (NICUs).
Gender:
All
Ages:
All
Trial Updated:
06/18/2023
Locations: Seattle Children's Hospital, Seattle, Washington +1 locations
Conditions: Postpartum Depression, Anxiety, Depression, Stress Disorder, Prematurity